Retatrutide (development code LY3437943 ) is a single synthetic peptide developed by Eli Lilly that acts as a triple agonist at three receptors simultaneously: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor
As the first telomerase-activating anti-aging drug, Epitalon signifies a shift from symptom-based treatments to mechanism-driven interventions, potentially extending human healthspan
The compound is not a supplement, cosmetic or therapeutic substance and any misuse outside of research applications is against regulatory guidelines and institutional policies
Reserve online Compare Injections Use the wellness injection hub if you are deciding between B12, NAD+, glutathione, and vitamin C
Frequently asked questions The injection site for MIC B12 shots is crucial for proper absorption and effectiveness
That said, the following titration table reflects the prevailing clinical approach used by longevity-focused practitioners, calibrated against the available pharmacological data